Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul Peter Tak currently holds 1,763,968 shares of Candel Therapeutics, Inc. (CADL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Peter Tak has been a net seller of CADL stock. They have purchased $230.0K and sold $266.9K worth of shares.
Paul Peter Tak's most recent insider trade was on Nov 21, 2024, when they sold 12,900 shares at $0.00 per share.
Paul Peter Tak serves as Executive at Candel Therapeutics, Inc. (CADL). They have executed 9 insider transactions totaling $496.9K over their tenure at the company.
Paul Peter Tak holds the position of Executive at Candel Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Paul Peter Tak has shown a selling trading pattern, with $230.0K in total purchases and $266.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Paul Peter Tak was on Jul 29, 2021, when they purchased $200.0K worth of CADL shares. This transaction involved 25,000 shares at $8.00 per share.
Paul Peter Tak currently owns 1,763,968 shares of Candel Therapeutics, Inc. (CADL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul Peter Tak's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul Peter Tak has 9 Form 4 filings on record as an insider at Candel Therapeutics, Inc..
Set alerts for Paul Peter Tak and 40,000+ other insiders.